ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2015 American Transplant Congress

    Sex Differences in Mortality Rate Among Patients Waiting for Liver Transplantation

    Z. Cui,1,2 X. Luo,2 A. Massie,2 D. Segev.2

    1Columbia University, New York; 2Johns Hopkins University, Baltimore.

    Livers are allocated according to MELD score without regard to patient demographics. However, MELD-adjusted risk of death may vary by sex, since serum creatinine level…
  • 2015 American Transplant Congress

    Etanercept for Graft Versus Host Disease Following Liver Transplantation

    E. Ticehurst,1 E. Blumberg,1 F. Vyas,1 K. Olthoff,1 A. Shaked,1 S. Bruno,1 K. Butcavage,1 E. Knight,1 G. Smith,1 S. Gill.2

    1Penn Transplant Institute, Phila, PA; 2Hematology-Oncology, Dept of Medicine, Univ of Penn, Phila, PA.

    Purpose: Graft versus host disease (GVHD) is a devastating diagnosis and treatment options, such as antithymocyte globulin (ATG), have poor response rates. With a goal…
  • 2015 American Transplant Congress

    Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients

    A. Daoud,1,3 M. Ghobrial,1 L. Teeter,2 E. Graviss,2 E. Asham,1 S. Burroughs,1 A. Saharia,1 C. Mobley,1 S. Mogawer,3 A. Sholkamy,3 M. Elshazly,4 M. Boktour,1 A. Gaber.1

    1Transplant Center, Methodist Hospital, Houston, TX; 2Pathology and Genomic Medicine, Methodist Hospital, Houston, TX; 3Internal Medicine Department, Cairo University Medical school, Cairo, Egypt; 4Surgery Department, Cairo University Medical school, Cairo, Egypt.

    Background:The current listing criteria (Milan, UCSF) for Orthotropic Liver Transplants (OLT) in hepatocellular carcinoma (HCC) patients emphasize the anatomic features of the tumor such as…
  • 2015 American Transplant Congress

    The Impact of Critical Illness and Pre-Transplant Hospitalization on Cost of Liver Transplantation

    S. Knechtle, L. Brummett, S. Perez.

    Surgery, Emory University School of Medicine, Atlanta, GA.

    In order to understand the cost impact of hospitalization and ICU admission immediately prior to liver transplantation (LT), we obtained all hospital costs associated with…
  • 2015 American Transplant Congress

    Is Transplant Volume Associated With Survival in Pediatric Liver Transplants?

    W. Cherikh,1 H. Kim,2 A. Wilk,1 C. Flavin,1 E. Brewer.3

    1United Network for Organ Sharing, Richmond, VA; 2Boston Children's Hospital, Boston, MA; 3Baylor Coll Med & Texas Children's Hosp, Houston, TX.

    Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current study was conducted to determine…
  • 2015 American Transplant Congress

    Hepatocyte-Related miR-193a-3p Is Over-Expressed in Allograft Biopsy from Liver Tolerant Recipients

    R. Danger, J. Lozano, E. Bonaccorsi-Riani, E. Kodela, R. Mas-Malavila, M.-C. Londono, M. Martinez, A. Rimola, M. Martinez-Llordella, A. Sanchez-Fueyo.

    Department of Liver Sciences, Faculty of Life Sciences & Medicine, MRC Transplant Centre, King's College London, London, United Kingdom; Liver Unit and Bioinformatic Platform, IDIBAPS, University of Barcelona and Hospital Clinic Barcelona, Barcelona, Spain.

    While liver transplantation is the treatment of choice for end-stage liver diseases, its success is compromised by the need to administer life-long immunosuppression, which negatively…
  • 2015 American Transplant Congress

    Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial

    B. Eghtesad, K. Hashimoto, M. Watson, M. Nazzal, C. Quintini, D. Kelly, T. Diago, N. Kawamura, G. El-Gazzaz, M. Fujiki, F. Aucejo, C. Winans, C. Miller, J. Fung.

    Hepatobiliary and Liver Transplant Surgery, Cleveland Clinic, Cleveland, OH.

    To further evaluate the impact of tPA in reduction of ITBS in livers recovered from the DCD donors we conducted a controlled randomized trial. Between…
  • 2015 American Transplant Congress

    Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation

    S. Alexopoulos,1 V. Nekrasov,1 L. Matsuoka,1 K. Chouliaras,2 Y. Genyk.1

    1Department of Surgery, Keck Medical Center of USC, Los Angeles, CA; 2Department of Surgery, Wake Forest University, Winston-Salem, NC.

    Purpose: To determine the benefit of living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) in the treatment of end stage liver…
  • 2015 American Transplant Congress

    Outcomes of Hepatitis C Virus (HCV) Treatment Following Liver Transplantation in the Era of Direct-Acting Antiviral Medications

    S. Baggett,1 D. Jones,1 M. Shoreibah.2

    1Department of Pharmacy, UAB Hospital, Birmingham, AL; 2Department of Gastroenterology, UAB Hospital, Birmingham, AL.

    BACKGROUND: The treatment of HCV is one of the most rapidly changing areas of medical practice. These agents have been shown to be safe and…
  • 2015 American Transplant Congress

    Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation

    P. De Simone,1 P. Carrai,1 L. Coletti,1 D. Ghinolfi,1 D. Campani,2 F. Filipponi.1

    1Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy; 2Pathology, University of Pisa Medical School Hospital, Pisa, Italy.

    Background and aim: The inhibitor of the mammalian target of rapamycin (mTOR) everolimus (EVR) has shown anti-proliferative effects in experimental and clinical models. We investigated…
  • « Previous Page
  • 1
  • …
  • 177
  • 178
  • 179
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences